Research ArticleOriginal Article
Open Access

Clinical and epidemiological characteristics of COVID-19 mortality in Saudi Arabia

Rawabi M. Alsayer, Hassan M. Alsharif, Abeer M. Al Baadani and Kiran A. Kalam
Saudi Medical Journal October 2021, 42 (10) 1083-1094; DOI: https://doi.org/10.15537/smj.2021.42.10.20210396

References

  1. 1.↵
    Ministry of Health. COVID-19 coronavirus disease guidelines [Internet]. Saudi CDC; 2020 [Updated 2020; Accessed 2020 Jun 03]. Available from: https://www.moh.gov.sa/Ministry/MediaCenter/Publications/Documents/Coronavirus-Disease-2019-Guidelines-v1.2.pdf
  2. 2.↵
    World Health Organization. Clinical management of severe acute respiratory infection when novel coronavirus (nCoV) infection is suspected. [Updated 2020. Accessed 2020 Aug 20]. Available from: https://www.who.int/publications/i/item/10665-332299
  3. 3.↵
    World Health Organization. Report of the WHO-China Joint Mission on Coronavirus Disease 2019 (COVID-19). [Updated 2020. Accessed 2020 Jun 06]. Available from: https://www.who.int/publications/i/item/report-of-the-who-china-joint-mission-on-coronavirus-disease-2019-(covid-19)
  4. 4.↵
    1. Guan WJ,
    2. Ni ZY,
    3. Hu Y,
    4. Liang WH,
    5. Ou CQ,
    6. He JX, et al.
    Clinical characteristics of coronavirus disease 2019 in China. N Engl J Med 2020; 382: 1708-1720.
    OpenUrlCrossRefPubMed
  5. 5.↵
    1. Docherty AB,
    2. Harrison EM,
    3. Green CA,
    4. Hardwick HE,
    5. Pius R,
    6. Norman L, et al.
    Features of 20133 UK patients in hospital with covid-19 using the ISARIC WHO clinical characterisation protocol: prospective observational cohort study. BMJ 2020; 369: m1985.
    OpenUrlAbstract/FREE Full Text
  6. 6.↵
    1. Liang LL,
    2. Tseng CH,
    3. Ho HJ,
    4. Wu CY.
    Covid-19 mortality is negatively associated with test number and government effectiveness. Sci Rep 2020; 10: 12567.
    OpenUrl
  7. 7.↵
    1. Chen T,
    2. Wu D,
    3. Chen H,
    4. Yan W,
    5. Yang D,
    6. Chen G, et al.
    Clinical characteristics of 113 deceased patients with coronavirus disease 2019: retrospective study. BMJ 2020; 368: m1091.
    OpenUrlAbstract/FREE Full Text
  8. 8.↵
    Ministry of Health. Information about COVID-19 - Coronavirus in Saudi Arabia. [Updated 2020; Accessed 2020 Jun 9] Available from: https://www.moh.gov.sa/en/Ministry/MediaCenter/Publications/Pages/covid19.aspx
  9. 9.↵
    1. Alsofayan YM,
    2. Althunayyan SM,
    3. Khan AA,
    4. Hakawi AM,
    5. Assiri AM.
    Clinical characteristics of COVID-19 in Saudi Arabia: a national retrospective study. J Infect Public Health 2020; 13: 920-925.
    OpenUrl
  10. 10.↵
    World Health Organization. WHO Coronavirus disease (COVID-19) technical guidance: Laboratory testing for 2019-nCoV in humans. [Updated 2020. Accessed 2020 Sep 06] Available from: https://www.who.int/emergencies/diseases/novel-coronavirus-2019/technical-guidance-publications
  11. 11.↵
    1. Harrington RA.
    Case fatality rate. Encyclopedia Britannica. [Updated 2020 May 5; Accessed 2020 Sep 06] Available from: https://www.britannica.com/science/case-fatality-rate
  12. 12.↵
    1. Ryan M,
    2. Levy MM.
    Clinical review: fever in intensive care unit patients. Crit Care 2003; 7: 221-225.
    OpenUrlCrossRefPubMedWeb of Science
  13. 13.↵
    World Health Organization. International guidelines for certification and classification (coding) of COVID-19 as cause of death. Based on ICD International Statistical Classification of Diseases. [Updated 2020 April 16; Accessed 2020 Jul 04] Available from: https://www.who.int/classifications/icd/Guidelines_Cause_of_Death_COVID-19.pdf
  14. 14.↵
    1. Williamson EJ,
    2. Walker AJ,
    3. Bhaskaran K,
    4. Bacon S,
    5. Bates C,
    6. Morton CE, et al.
    Factors associated with COVID-19-related death using OpenSAFELY. Nature 2020; 584: 430-436.
    OpenUrlCrossRefPubMed
  15. 15.↵
    NIAID-RML. Coronavirus disease 2019 (COVID-19) treatment guidelines [updated 2020; Accessed 2020 Jul 09]. Available from: https://www.covid19treatmentguidelines.nih.gov/
  16. 16.↵
    1. Shahid R,
    2. Umar M,
    3. Zafar RB,
    4. Zeb S,
    5. Ambreen S,
    6. Akram MO.
    Comorbidity of COVID-19 related fatalities in tertiary care hospitals of Rawalpindi, Pakistan. J Rawalpindi Med Coll 2020; 24.
  17. 17.↵
    1. Biagi A,
    2. Rossi L,
    3. Malagoli A,
    4. Zanni A,
    5. Sticozzi C,
    6. Comastri G, et al.
    Clinical and epidemiological characteristics of 320 deceased patients with COVID-19 in an Italian Province: a retrospective observational study. J Med Virol 2020; 92: 2718-2724.
    OpenUrlCrossRef
  18. 18.↵
    1. Goel S,
    2. Jain T,
    3. Hooda A,
    4. Malhotra R,
    5. Johal G,
    6. Masoomi R, et al.
    Clinical characteristics and in-hospital mortality for COVID-19 across the globe. Cardiol Ther 2020; 9: 553-559.
    OpenUrl
  19. 19.↵
    1. Berenguer J,
    2. Ryan P,
    3. Rodríguez-Baño J,
    4. Jarrín I,
    5. Carratalà J,
    6. Pachón J, et al.
    Characteristics and predictors of death among 4035 consecutively hospitalized patients with COVID-19 in Spain. Clin Microbiol Infect 2020; 26: 1525-1536.
    OpenUrlCrossRefPubMed
  20. 20.↵
    1. Hultström M,
    2. Persson B,
    3. Eriksson O,
    4. Lipcsey M,
    5. Frithiof R,
    6. Nilsson B.
    Blood type A associates with critical COVID-19 and death in a Swedish cohort. Crit Care 2020; 24: 496.
    OpenUrlCrossRef
  21. 21.↵
    1. Zietz M,
    2. Zucker J,
    3. Tatonetti NP.
    Associations between blood type and COVID-19 infection, intubation, and death. Nat Commun 2020; 11: 5761.
    OpenUrlCrossRefPubMed
  22. 22.↵
    1. Ad’hiah AH,
    2. Allami RH,
    3. Mohsin RH,
    4. Abdullah MH,
    5. AL-Sa’ady AJR,
    6. Alsudani MY.
    Evaluating of the association between ABO blood groups and coronavirus disease 2019 (COVID-19) in Iraqi patients. Egypt J Med Hum Genet 2020.
  23. 23.↵
    1. Pourali F,
    2. Afshari M,
    3. Alizadeh-Navaei R,
    4. Javidnia J,
    5. Moosazadeh M,
    6. Hessami A.
    Relationship between blood group and risk of infection and death in COVID-19: a live meta-analysis. New Microbes New Infect 2020; 37: 100743.
    OpenUrl
  24. 24.↵
    1. Grasselli G,
    2. Greco M,
    3. Zanella A,
    4. Albano G,
    5. Antonelli M,
    6. Bellani G, et al.
    Risk factors associated with mortality among patients with COVID-19 in intensive care units in Lombardy, Italy. JAMA Intern Med 2020; 180: 1345-1355.
    OpenUrlPubMed
  25. 25.↵
    1. Garg S,
    2. Kim L,
    3. Whitaker M,
    4. O’Halloran A,
    5. Cummings C,
    6. Holstein R, et al.
    Hospitalization rates and characteristics of patients hospitalized with laboratory-confirmed coronavirus disease 2019 - COVID-NET, 14 states, March 1-30, 2020. MMWR Morb Mortal Wkly Rep 2020; 69: 458-464.
    OpenUrlCrossRefPubMed
  26. 26.↵
    1. Kumar A,
    2. Arora A,
    3. Sharma P,
    4. Anikhindi SA,
    5. Bansal N,
    6. Singla V, et al.
    Is diabetes mellitus associated with mortality and severity of COVID-19? A meta-analysis. Diabetes Metab Syndr 2020; 14: 535-545.
    OpenUrlPubMed
  27. 27.↵
    1. Schultze A,
    2. Walker AJ,
    3. MacKenna B,
    4. Morton CE,
    5. Bhaskaran K,
    6. Brown JP, et al.
    Risk of COVID-19-related death among patients with chronic obstructive pulmonary disease or asthma prescribed inhaled corticosteroids: an observational cohort study using the OpenSAFELY platform. Lancet Respir Med 2020; 8: 1106-1120.
    OpenUrl
  28. 28.↵
    1. Dietz W,
    2. Santos-Burgoa C.
    Obesity and its implications for COVID-19 mortality. Obesity (Silver Spring) 2020; 28: 1005.
    OpenUrl
  29. 29.↵
    1. Li X,
    2. Wang L,
    3. Yan S,
    4. Yang F,
    5. Xiang L,
    6. Zhu J, et al.
    Clinical characteristics of 25 death cases with COVID-19: a retrospective review of medical records in a single medical center, Wuhan, China. Int J Infect Dis 2020; 94: 128-132.
    OpenUrlCrossRef
  30. 30.↵
    1. Shi S,
    2. Qin M,
    3. Shen B,
    4. Cai Y,
    5. Liu T,
    6. Yang F, et al.
    Association of cardiac injury with mortality in hospitalized patients with COVID-19 in Wuhan, China. JAMA Cardiol 2020; 5: 802-810.
    OpenUrlPubMed
  31. 31.↵
    1. Gibson PG,
    2. Qin L,
    3. Puah SH.
    COVID-19 acute respiratory distress syndrome (ARDS): clinical features and differences from typical pre-COVID-19 ARDS. Med J Aust 2020; 213: 54-56.
    OpenUrlCrossRef
  32. 32.↵
    1. Lai CC,
    2. Wang CY,
    3. Hsueh PR.
    Co-infections among patients with COVID-19: the need for combination therapy with non-anti-SARS-CoV-2 agents? J Microbiol Immunol Infect 2020; 53: 505-512.
    OpenUrlCrossRefPubMed
  33. 33.↵
    1. Lansbury L,
    2. Lim B,
    3. Baskaran V,
    4. Lim WS.
    Co-infections in people with COVID-19: a systematic review and meta-analysis. J Infect 2020; 81: 266-275.
    OpenUrlPubMed
  34. 34.↵
    1. Calabrese F,
    2. Pezzuto F,
    3. Fortarezza F,
    4. Hofman P,
    5. Kern I,
    6. Panizo A, et al.
    Pulmonary pathology and COVID-19: lessons from autopsy. The experience of European pulmonary pathologists. Virchows Arch 2020; 477: 359-372.
    OpenUrlCrossRefPubMed
  35. 35.↵
    1. Oussalah A,
    2. Gleye S,
    3. Urmes IC,
    4. Laugel E,
    5. Barbé F,
    6. Orlowski S, et al.
    The spectrum of biochemical alterations associated with organ dysfunction and inflammatory status and their association with disease outcomes in severe COVID-19: a longitudinal cohort and time-series design study. EClinicalMedicine 2020; 27: 100554.
    OpenUrl
  36. 36.↵
    1. Qin C,
    2. Zhou L,
    3. Hu Z,
    4. Zhang S,
    5. Yang S,
    6. Tao Y, et al.
    Dysregulation of immune response in patients with coronavirus 2019 (COVID-19) in Wuhan, China. Clin Infect Dis 2020; 71: 762-768.
    OpenUrlCrossRefPubMed
  37. 37.↵
    1. Zhou F,
    2. Yu T,
    3. Du R,
    4. Fan G,
    5. Liu Y,
    6. Liu Z, et al.
    Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study. Lancet 2020; 395: 1054-1062.
    OpenUrlCrossRefPubMed
  38. 38.↵
    1. Asghar MS,
    2. Haider Kazmi SJ,
    3. Khan NA,
    4. Akram M,
    5. Hassan M,
    6. Rasheed U, et al.
    Poor prognostic biochemical markers predicting fatalities caused by COVID-19: a retrospective observational study from a developing country. Cureus 2020; 12: e9575.
    OpenUrl
  39. 39.↵
    1. Ji Y,
    2. Ma Z,
    3. Peppelenbosch MP,
    4. Pan Q.
    Potential association between COVID-19 mortality and health-care resource availability. Lancet Glob Health 2020; 8: e480.
    OpenUrl
  40. 40.↵
    1. Bambra C,
    2. Riordan R,
    3. Ford J,
    4. Matthews F.
    The COVID-19 pandemic and health inequalities. J Epidemiol Community Health 2020; 74: 964-968.
    OpenUrlAbstract/FREE Full Text
Back to top

In this issue

Print
Download PDF
Email Article
Citation Tools
Bookmark this article

Jump to section

Keywords